Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2014, Article ID 203512, 9 pages
http://dx.doi.org/10.1155/2014/203512
Clinical Study

L-Arginine/NO Pathway Is Altered in Children with Haemolytic-Uraemic Syndrome (HUS)

1Department of Paediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Carl-Neuberg-Straße 1, 30625 Hannover, Germany
2Institute of Clinical Pharmacology, Hannover Medical School, Carl-Neuberg-Straße 1, 30625 Hannover, Germany
3Department of Paediatrics, University of Mainz, Langenbeckstraße 1, 55131 Mainz, Germany
4Institute of Biometry, Hannover Medical School, Carl-Neuberg-Straße 1, 30625 Hannover, Germany
5Department of Medicine III, Klinikum Fulda, Pacelliallee 4, 36043 Fulda, Germany
6Department of Neuropaediatrics, University Children’s Hospital, Ruhr University Bochum, Gudrunstraße 56, 44791 Bochum, Germany

Received 6 January 2014; Accepted 11 February 2014; Published 17 March 2014

Academic Editor: Daniela Giustarini

Copyright © 2014 Nele Kirsten Kanzelmeyer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Nele Kirsten Kanzelmeyer, Lars Pape, Kristine Chobanyan-Jürgens, et al., “L-Arginine/NO Pathway Is Altered in Children with Haemolytic-Uraemic Syndrome (HUS),” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 203512, 9 pages, 2014. https://doi.org/10.1155/2014/203512.